Cargando…

Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα

We previously identified a quantitative trait locus for adiposity, non-insulin-dependent diabetes 5 (Nidd5), on mouse chromosome 2. In the current study, we identified the actual genetic alteration at Nidd5 as a nonsense mutation of the Acvr1c gene encoding activin receptor-like kinase 7 (ALK7), one...

Descripción completa

Detalles Bibliográficos
Autores principales: Yogosawa, Satomi, Mizutani, Shin, Ogawa, Yoshihiro, Izumi, Tetsuro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526038/
https://www.ncbi.nlm.nih.gov/pubmed/22933117
http://dx.doi.org/10.2337/db12-0295
_version_ 1782253494762209280
author Yogosawa, Satomi
Mizutani, Shin
Ogawa, Yoshihiro
Izumi, Tetsuro
author_facet Yogosawa, Satomi
Mizutani, Shin
Ogawa, Yoshihiro
Izumi, Tetsuro
author_sort Yogosawa, Satomi
collection PubMed
description We previously identified a quantitative trait locus for adiposity, non-insulin-dependent diabetes 5 (Nidd5), on mouse chromosome 2. In the current study, we identified the actual genetic alteration at Nidd5 as a nonsense mutation of the Acvr1c gene encoding activin receptor-like kinase 7 (ALK7), one of the type I transforming growth factor-β receptors, which results in a COOH-terminal deletion of the kinase domain. We further showed that the ALK7 dysfunction causes increased lipolysis in adipocytes and leads to decreased fat accumulation. Conversely, ALK7 activation inhibits lipolysis by suppressing the expression of adipose lipases. ALK7 and activated Smads repress those lipases by downregulating peroxisome proliferator–activated receptor γ (PPARγ) and CCAAT/enhancer binding protein (C/EBP) α. Although PPARγ and C/EBPα act as adipogenic transcription factors during adipocyte differentiation, they are lipolytic in sum in differentiated adipocytes and are downregulated by ALK7 in obesity to accumulate fat. Under the obese state, ALK7 deficiency improves glucose tolerance and insulin sensitivity by preferentially increasing fat combustion in mice. These findings have uncovered a net lipolytic function of PPARγ and C/EBPα in differentiated adipocytes and point to the ALK7-signaling pathway that is activated in obesity as a potential target of medical intervention.
format Online
Article
Text
id pubmed-3526038
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35260382014-01-01 Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα Yogosawa, Satomi Mizutani, Shin Ogawa, Yoshihiro Izumi, Tetsuro Diabetes Obesity Studies We previously identified a quantitative trait locus for adiposity, non-insulin-dependent diabetes 5 (Nidd5), on mouse chromosome 2. In the current study, we identified the actual genetic alteration at Nidd5 as a nonsense mutation of the Acvr1c gene encoding activin receptor-like kinase 7 (ALK7), one of the type I transforming growth factor-β receptors, which results in a COOH-terminal deletion of the kinase domain. We further showed that the ALK7 dysfunction causes increased lipolysis in adipocytes and leads to decreased fat accumulation. Conversely, ALK7 activation inhibits lipolysis by suppressing the expression of adipose lipases. ALK7 and activated Smads repress those lipases by downregulating peroxisome proliferator–activated receptor γ (PPARγ) and CCAAT/enhancer binding protein (C/EBP) α. Although PPARγ and C/EBPα act as adipogenic transcription factors during adipocyte differentiation, they are lipolytic in sum in differentiated adipocytes and are downregulated by ALK7 in obesity to accumulate fat. Under the obese state, ALK7 deficiency improves glucose tolerance and insulin sensitivity by preferentially increasing fat combustion in mice. These findings have uncovered a net lipolytic function of PPARγ and C/EBPα in differentiated adipocytes and point to the ALK7-signaling pathway that is activated in obesity as a potential target of medical intervention. American Diabetes Association 2013-01 2012-12-13 /pmc/articles/PMC3526038/ /pubmed/22933117 http://dx.doi.org/10.2337/db12-0295 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Obesity Studies
Yogosawa, Satomi
Mizutani, Shin
Ogawa, Yoshihiro
Izumi, Tetsuro
Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
title Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
title_full Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
title_fullStr Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
title_full_unstemmed Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
title_short Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα
title_sort activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator–activated receptor γ and c/ebpα
topic Obesity Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526038/
https://www.ncbi.nlm.nih.gov/pubmed/22933117
http://dx.doi.org/10.2337/db12-0295
work_keys_str_mv AT yogosawasatomi activinreceptorlikekinase7suppresseslipolysistoaccumulatefatinobesitythroughdownregulationofperoxisomeproliferatoractivatedreceptorgandcebpa
AT mizutanishin activinreceptorlikekinase7suppresseslipolysistoaccumulatefatinobesitythroughdownregulationofperoxisomeproliferatoractivatedreceptorgandcebpa
AT ogawayoshihiro activinreceptorlikekinase7suppresseslipolysistoaccumulatefatinobesitythroughdownregulationofperoxisomeproliferatoractivatedreceptorgandcebpa
AT izumitetsuro activinreceptorlikekinase7suppresseslipolysistoaccumulatefatinobesitythroughdownregulationofperoxisomeproliferatoractivatedreceptorgandcebpa